Clinical updates, including trial initiations, enrollment status and data readouts and publications: Actuate, Alx, Ammax, Armaris, Aquestive, Biontech, Bold, Boehringer-Ingelheim, Catalym, Chromadex, Cytokinetics, Durect, Elgan, Genprex, Harm Reduction, Immvira, Inflarx, Innocoll, Inovio, Isa, Intellia, Kalvista, Kintor, Knopp, Lexeo, Mind Medicine, Minerva, Neurogenesis, Newamsterdam, Nicox, Novavax, Pfizer, Projenx, Polypid, Redhill, Regeneron, SAB, Xalud.